Recently, the Department of Pharmaceuticals announced the second call for applications under the Promotion of Research and Innovation in Pharma and MedTech (PRIP) Scheme.
The PRIP Scheme was launched in 2023 by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. It aims to transform India into a global powerhouse for research and development (R&D) in the pharmaceutical and medical technology sectors.
The scheme has a total financial outlay of ₹5,000 crore.
Its primary objective is to promote industry–academia collaboration in research and development in priority areas, develop a culture of quality research, and nurture India’s pool of scientists.
Initiatives such as MedTech Mitra, Patent Mitra and the online platform under the scheme are intended to facilitate collaboration and partnerships among stakeholders.
Component A focuses on strengthening research infrastructure through the establishment of Centres of Excellence (CoEs) in the seven existing National Institutes of Pharmaceutical Education and Research (NIPERs).
These centres are intended to be established in pre-identified research areas, with a financial outlay of ₹700 crore.
Component B promotes research in the pharmaceutical sector across six priority areas. Financial assistance is provided to industries, MSMEs, SMEs and startups working with government institutions, covering both in-house and academic research.
Under this component, assistance varies according to the stage and cost of the project.
Early-stage projects: MSMEs and startups may apply for projects costing up to ₹9 crore, with financial assistance of up to ₹5 crore.
Later-stage projects: Industries, MSMEs and startups may apply for projects costing up to ₹285 crore, with financial assistance of up to ₹100 crore.
The scheme focuses on the following six priority areas.
Research is encouraged into new chemical entities, new biological entities and plant-derived pharmaceutical products.
The scheme supports research in complex generic medicines and biosimilars, which are important areas of pharmaceutical innovation.
It promotes research in precision medicine and targeted innovative therapeutics, which aim to provide treatments targeted to specific conditions or patient groups.
Research in medical devices and medical technology is a priority area for strengthening domestic innovation in the MedTech sector.
The scheme encourages research into orphan drugs, which are developed to address rare diseases.
Research is supported for developing drugs to address antimicrobial resistance (AMR), an important public health challenge.
The PRIP Scheme seeks to strengthen India’s pharmaceutical and MedTech research ecosystem by improving research infrastructure, encouraging industry–academia partnerships, and supporting innovation across different stages of project development.
Its emphasis on new medicines, complex generics, precision medicine, medical devices and antimicrobial resistance aims to expand domestic research capabilities and contribute to India’s role in global pharmaceutical innovation.
We provide offline, online and recorded lectures in the same amount.
Every aspirant is unique and the mentoring is customised according to the strengths and weaknesses of the aspirant.
In every Lecture. Director Sir will provide conceptual understanding with around 800 Mindmaps.
We provide you the best and Comprehensive content which comes directly or indirectly in UPSC Exam.
If you haven’t created your account yet, please Login HERE !
We provide offline, online and recorded lectures in the same amount.
Every aspirant is unique and the mentoring is customised according to the strengths and weaknesses of the aspirant.
In every Lecture. Director Sir will provide conceptual understanding with around 800 Mindmaps.
We provide you the best and Comprehensive content which comes directly or indirectly in UPSC Exam.
Offline/Online Class
